How Hospital Monopolies Are Pushing Up Your Medical Bills

Hospital consolidation is touching a large share of U.S. spending

Health care takes up nearly one in every five dollars spent in the U.S. economy. When local hospitals face less competition, that spending burden tends to rise with it.

Hospitals are the biggest piece of that bill. They account for roughly 31% of all healthcare spending-more than physician services and retail prescription drugs combined. That is why hospital market power is not a niche policy issue. It can affect premiums, deductibles, employer costs, and household budgets all at once.

This has also become a live political issue. Strong non-partisan support is forming around policies to address hospital costs, and the April 2026 poll shows Americans want Congress to act. That does not guarantee legislation in an election year, but it does increase the odds of tougher antitrust scrutiny, transparency pressure, and stronger payer resistance.

The human impact is straightforward. When competition fades, patients can be left choosing between taking on financial hardship to afford care and going without care.

Why less competition tends to raise prices

The issue is not just fewer hospital buildings. It is fewer independent bargaining partners.

How higher prices spread through insurance negotiations

When a hospital network is one of only a few options in a region, insurers have less room to push back on price. That matters because about 90% of U.S. hospital markets are highly concentrated. In those markets, hospitals can demand higher negotiated rates. The effect can be large: HHS data cited by the Bipartisan Policy Center says hospital-to-hospital mergers in concentrated markets can raise prices by 6% to 65%.

Consolidation is spreading from hospitals into physician practices

The same pattern is moving beyond hospital walls. According to the Bipartisan Policy Center, the share of hospitals operating independently fell from about 90% in 1970 to 32% in 2019. The same source says hospitals' acquisition of physician practices has been linked to a 14% average increase in prices for physicians' services. In practical terms, consolidation is not just changing the hospital landscape; it is also reshaping where and at what price outpatient care is delivered.

The pro-merger argument has not translated into lower consumer costs

Hospitals do make a credible case for integration: better care coordination, help for financially strained rural providers, and economies of scale. But the consumer payoff has been weak. Research cited by the American Progress says efficiency often does not materialize, and even when it does, savings are not passed on to consumers. The clearer pattern is that concentrated markets tend to have higher prices.

Antitrust enforcement is real, but the battlefield is uneven

Government action is already happening

This is not just a theoretical debate. In the first three months of 2026, the FTC and DOJ were pursuing merger challenges, civil lawsuits, and criminal prosecutions. Private antitrust cases also continued on related issues such as algorithmic pricing and group purchasing organizations.

For investors, the point is not whether antitrust is fully "on" or "off." It is that enforcement remains a practical tool against hospital bargaining power, especially where markets are already tight. Even after about 90% of U.S. hospital markets are highly concentrated, regulators can still target the next wave of expansion before that power becomes more entrenched.

Some hospitals still have legal shields

The enforcement landscape is uneven. One growing flashpoint involves academic medical centers. At least four states have laws explicitly protecting their state-university academic medical centers from some form of antitrust oversight, or have considered such legislation. That means some deals may face scrutiny while others slip through because the buyer has a political or legal shield.

Site-of-service pricing can extend consolidation's effect

Enforcement alone will not reverse years of consolidation. That is why payment rules still matter. If hospital-owned physician offices can be paid at the same higher rates as hospitals, then acquiring local practices becomes more than an operational move-it becomes a pricing move. Consolidation explains how hospitals got stronger. Payment policy helps determine how far that strength can spread.

If oversight stays selective, prices can keep finding room to rise even without another headline merger.

What to watch next

The next moves matter more than the diagnosis. With FTC and DOJ enforcement continuing through 2026 and voters still showing strong non-partisan support for action on hospital costs, the near-term debate is about policy and deal flow rather than abstract market theory.

The main signals to watch

• Merger challenges and lawsuit outcomes. If regulators can still block or slow deals, they can directly limit future pricing power.
• State protection of academic medical centers. If more hospitals get legal shields, some consolidations may face less scrutiny.
• Payment rules for hospital-owned facilities. If separate billing rules keep favoring hospital-owned offices, consolidation can keep lifting prices even without major new hospital mergers.